Dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

被引：0
|
作者：
Mey, U
Orlopp, K
Flieger, D
Strehl, J
Ho, A
Hensel, M
Birkmann, J
Wilhelm, M
Kaiser, U
Neubauer, A
Glasmacher, A
Schmidt-Wolf, I
机构：
[1] Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany
[2] Klinikum Aschaffenburg, Dept Internal Med 2, Aschaffenburg, Germany
[3] Univ Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[4] Univ Marburg, Dept Hematol Onkol & Immunol, Marburg, Germany
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
489
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [1] Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
    Mey, Ulrich J. M.
    Orlopp, Katjana S.
    Flieger, Dimitri
    Strehl, John W.
    Ho, Anthony D.
    Hensel, Manfred
    Bopp, Cordula
    Gorschlueter, Marcus
    Wilhelm, Martin
    Birkmann, Josef
    Kaiser, Ulrich
    Neubauer, Andreas
    Florschuetz, Axel
    Rabe, Christian
    Hahn, Corinna
    Glasmacher, Axel G.
    Schmidt-Wolf, Ingo G. H.
    [J]. CANCER INVESTIGATION, 2006, 24 (06) : 593 - 600
  • [2] A phase II trial of dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab as salvage treatment for patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
    Mey, UJM
    Strehl, JW
    Orlopp, KS
    Flieger, D
    Birkmann, J
    Ho, A
    Kaiser, U
    Neubauer, A
    Glasmacher, AG
    Schmidt-Wolf, IGH
    [J]. BLOOD, 2004, 104 (11) : 238B - 238B
  • [3] Salvage treatment for patients with refractory or relapsed aggressive non-Hodgkin's lymphoma with dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab: Preliminary results of a multicenter phase it trial.
    Mey, U
    Flieger, D
    Birkmann, J
    Ho, A
    Huhn, D
    Kaiser, U
    Ko, Y
    Kraemer, A
    Neubauer, A
    Wilhelm, M
    Hahn, C
    Haarmann, G
    Glasmacher, A
    Schmidt-Wolf, I
    [J]. BLOOD, 2002, 100 (11) : 309B - 309B
  • [4] Dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab as salvage treatment for patients with refractory or relapsed aggressive non-Hodgkin's lymphoma: Updated results of a multicenter phase II trial.
    Mey, UJM
    Flieger, D
    Birkmann, J
    Neubauer, A
    Ho, AD
    Kaiser, U
    Wilhelm, M
    Haarmann, G
    Hahn, C
    Strehl, JW
    Glasmacher, AG
    Schmidt-Wolf, IGH
    [J]. BLOOD, 2003, 102 (11) : 300B - 301B
  • [5] Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma
    Machover, D
    Delmas-Marsalet, B
    Misra, SC
    Gumus, Y
    Goldschmidt, E
    Schilf, A
    Frénoy, N
    Emile, JF
    Debuire, B
    Guettier, C
    Farrokhi, P
    Boulefdaoui, B
    Norol, F
    Parquet, N
    Ulusakarya, A
    Jasmin, C
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (10) : 1439 - 1443
  • [6] High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma
    Wang, WS
    Tzeng, CH
    Chiou, TJ
    Liu, JH
    Hsieh, RK
    Yen, CC
    Chen, PM
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (03) : 154 - 157
  • [7] Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Ghielmin, M
    Benedetti, F
    Tarella, C
    Zaglio, F
    Vitolo, U
    Di Nicola, M
    Pogliani, E
    Cavalli, F
    Gianni, AM
    Barbui, T
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (02) : 333 - 341
  • [8] Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
    Oki, Yasuhiro
    Ogura, Michinori
    Kato, Harumi
    Kikuchi, Ako
    Taji, Hirofumi
    Kagami, Yoshitoyo
    Oshiro, Aya
    Tsujimura, Akane
    Yamamoto, Kazuhito
    Morishima, Yasuo
    [J]. CANCER SCIENCE, 2008, 99 (01) : 179 - 184
  • [9] Treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma with a combination of a taxane, cyclophosphamide and rituximab.
    Krämer, A
    Zoz, M
    Krasniqi, F
    Görner, M
    Leo, E
    Ho, AD
    [J]. BLOOD, 2001, 98 (11) : 135A - 135A
  • [10] Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma
    Stamatoullas, A
    Fruchart, C
    Bastit, D
    Boulet, D
    Monconduit, M
    Piguet, H
    Tilly, H
    [J]. CANCER, 1996, 77 (11) : 2302 - 2307
12345